NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Return
12.08%
This Quarter Return
-2.2%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$714M
AUM Growth
+$37.8M
(+5.6%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
22.56%
Top 10 Holdings %
Top 10 Hldgs %
80.08%
Holding
30
New
8
Increased
5
Reduced
6
Closed
1
Top Buys
| 1 |
Milestone Pharmaceuticals
MIST
|
+$72.6M |
| 2 |
Apple
AAPL
|
+$53M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$52.4M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$7.03M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$6.17M |
Top Sells
| 1 |
Glaukos
GKOS
|
+$23M |
| 2 |
OrthoPediatrics
KIDS
|
+$19.3M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
+$3.23M |
| 4 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
+$3.06M |
| 5 |
DERM
Dermira, Inc.
DERM
|
+$2.72M |
Sector Composition
| 1 | Healthcare | 79.61% |
| 2 | Technology | 7.43% |
| 3 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
26
DELISTED
Intersect ENT, Inc
XENT
| $3.12M | 0.44% |
+136,885
| New | +$3.12M |
|
27
Cogent Biosciences
COGT
$1.77B
| $1.24M | 0.17% |
118,360
| – | – |
|
28
Protagonist Therapeutics
PTGX
$3.66B
| $289K | 0.04% |
+23,901
| New | +$289K |
|
|
DERM
29
DELISTED
Dermira, Inc.
DERM
| – | – |
-201,059
| Closed | -$2.72M |
|